Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details)

v3.21.2
Stockholders Equity (Details)
$ / shares in Units, pure in Thousands, $ in Thousands
 1 Months Ended 9 Months Ended
Jul. 28, 2021
shares
Jul. 26, 2021
USD ($)
$ / shares
shares
Mar. 30, 2021
$ / shares
Dec. 31, 2020
Sep. 30, 2021
USD ($)
Mar. 10, 2021
shares
Nov. 30, 2017
shares
May 31, 2017
$ / shares
shares
Stockholders Equity (Details) [Line Items]                
Market sales agreement, description       pursuant to a registration statement on Form S-3 declared effective by the Securities and Exchange Commission on December 11, 2020, the Company entered into an Open Market Sales Agreement (“ATM Agreement”) with Jefferies LLC. (“Jefferies”), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell shares of Common Stock with an aggregate offering price of up to $50,000, with Jefferies acting as sales agent. During the nine months ended September 30, 2021, the Company sold 743,964 shares of Common Stock under the ATM Agreement, at an average price of $7.19 per share, raising aggregate net proceeds of approximately $5,188, after deducting an aggregate commission of $160        
Aggregate shares   3,750,000,000            
Warrants sold to related party           362,383,000    
Vesting period     4 years          
Fair value at the grant date (in Dollars) | $         $ 5,138      
Shares of issued warrants           362,444,000    
License Agreement [Member]                
Stockholders Equity (Details) [Line Items]                
Warrants to purchase common stock               591,382,000
Common stock nominal value (in Dollars per share) | $ / shares               $ 0.1000
Stock Options [Member]                
Stockholders Equity (Details) [Line Items]                
Grant approved     985,530          
Exercise price (in Dollars per share) | $ / shares     $ 7,020.00          
Common Stock [Member]                
Stockholders Equity (Details) [Line Items]                
Aggregate shares   2,812,501,000            
Gross proceeds (in Dollars) | $   $ 15,000            
Sold price, per share (in Dollars per share) | $ / shares   $ 4,000            
Accompanying warrant to purchase share   750            
Exercise price (in Dollars per share) | $ / shares   $ 5,000            
Proceeds were received 125,000,000              
Warrants sold to related party 93,750,000              
Yeda [Member]                
Stockholders Equity (Details) [Line Items]                
Shares of issued warrants             7,615,000  
Scientific Founders [Member]                
Stockholders Equity (Details) [Line Items]                
Shares of issued warrants             2,974,000